|Articles|March 22, 2018

CDC's Uganda-Based Viral Surveillance Program Significantly Reduces Disease Detection Time

The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.

Detecting outbreaks of infectious diseases in Uganda just got faster thanks to an innovative program from the Centers for Disease Control and Prevention (CDC), in collaboration with the Uganda Ministry of Health (MOH), and the Uganda Virus Research Institute (UVRI).

Launched in Uganda in 2010 and dubbed the CDC-UVRI Viral Hemorrhagic Fever Surveillance and Laboratory Program, the CDC is reporting that the program has “identified 5 times as many outbreaks between 2010 and 2017 as were documented in the decade before the program began.” That boils down to the identification of viral hemorrhagic fevers (VHF) in about 2.5 days (per detection). The previous average detection time before the introduction of the program was 2 weeks.

According to the CDC, this program is the first-of-its-kind; “it combines real-time surveillance with laboratory testing and emergency response to significantly decrease both intensity and length of VHF outbreaks in the country, potentially saving hundreds or thousands of lives.”

The article’s lead author and program lead, CDC epidemiologist Trevor Shoemaker, spoke about the importance of early detection of infectious diseases in a news release, stating, “Early detection and response are key to protecting the public. By increasing surveillance and working together to catch outbreaks soon after they start, we can keep outbreaks small, preventing illnesses and deaths. This saves lives locally, and helps prevent the further spread of deadly diseases to other countries, including the United States.”

More than 11,000 human blood samples have been tested since 2010, resulting in the confirmation of 16 outbreaks of VHFs. The CDC broke the outbreaks down as follows: Ebola (3), Marburg hemorrhagic fever (3), Rift Valley Fever (4), and Crimean-Congo hemorrhagic fever (6).

Perhaps most importantly, though, because of the testing and surveillance, half of the outbreaks did not spread “beyond the first patient identified,” according to the news release. “One Ebola outbreak involved only 1 patient—the first documented outbreak of Ebola in Uganda that did not spread to other contacts in the community or health care facility where the patient was treated. By comparison, 2 Ebola outbreaks in 2000 and 2007, before the program, affected 425 and 131 people respectively.”

With the threat of VHFs particularly high in Uganda and other parts of sub-Saharan Africa, programs to rapidly detect outbreaks are imperative to keeping the populations safe. Technical and health communications materials on how to prevent VHFs that were developed as a result of this program are now being used in multiple African countries. In addition, more research has been initiated to understand how these viruses emerge and their circulation in animals.


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.
FAQ: XDR Shigella
Here is some important information around this pathogen and the intestinal infection.
The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.